Weight-loss drugs like Ozempic have been found to potentially help individuals with alcohol use disorder, according to a recent study published in JAMA Psychiatry. The study, which analyzed data from over 227,000 individuals in Sweden diagnosed with alcohol use disorder, revealed that those using drugs similar to Ozempic were less likely to be hospitalized for issues related to alcohol use disorder.
These drugs, known as GLP-1 agonists, mimic a hormone that helps regulate appetite and hunger. The study found that individuals using semaglutide (Ozempic) had a 36% lower risk of hospitalization, while those using liraglutide had a 28% lower risk. Additionally, the risk of hospitalization due to any substance use disorder was lower in those taking semaglutide by 32% and liraglutide by 22%.
While the results are promising, the study’s co-author, Markku Lähteenvuo, emphasized that further clinical trials are needed to confirm the direct impact of these drugs on addiction treatment. However, the findings contribute to a growing body of evidence suggesting that GLP-1 agonists could be effective in treating alcohol use disorder and addiction in general.
Previous research on GLP-1 drugs has shown potential in reducing alcohol intake, opioid overdose risk, and cannabis-use disorder relapse. These findings offer hope for the treatment of substance use disorder, a major public health concern.
Experts like Lorenzo Leggio and Patricia “Sue” Grigson acknowledge the significance of these findings but stress the importance of conducting clinical trials to validate the efficacy and safety of using these drugs for addiction treatment. While the initial results are promising, more research is needed to draw firm conclusions.
In conclusion, the study’s findings suggest a potential new approach to treating alcohol use disorder and addiction using drugs similar to Ozempic. Further research and clinical trials will help determine the effectiveness and safety of this treatment method, offering hope for individuals struggling with substance use disorder.
